Residency · Residency · Nephrology · includes a quiz

Glomerular Filtration and Renal Hemodynamics

Introduction

The kidneys receive approximately 20 to 25 percent of the total cardiac output, amounting to roughly 1.0 to 1.2 liters per minute, despite comprising less than one percent of total body weight. This remarkable disproportionality between organ size and blood flow underscores the central role of the kidneys in plasma filtration, solute homeostasis, and systemic hemodynamic regulation. Renal blood flow and glomerular filtration rate are tightly regulated through three interdependent mechanisms: intrinsic autoregulation, tubuloglomerular feedback, and neurohormonal modulation. A rigorous understanding of these renal hemodynamic principles is foundational for interpreting the pathophysiology of acute kidney injury, the progression of chronic kidney disease, and the mechanisms of action of pharmacologic interventions such as renin-angiotensin-aldosterone system blockers and sodium-glucose cotransporter 2 inhibitors.

Renal Vascular Anatomy and Blood Flow

Macrovascular Architecture

The renal artery enters the kidney at the hilum and branches sequentially into segmental arteries, interlobar arteries (which course between the medullary pyramids), arcuate arteries (which travel along the corticomedullary junction), and interlobular arteries (which ascend through the renal cortex). From the interlobular arteries, the afferent arterioles arise and deliver blood to the glomerular capillary tuft, the site of plasma ultrafiltration. After traversing the glomerular capillary network, blood exits through the efferent arteriole. In cortical nephrons, the efferent arteriole gives rise to the peritubular capillary network, which surrounds the proximal and distal tubules and is critical for tubular reabsorption and secretion. In juxtamedullary nephrons, the efferent arteriole descends into the medulla as the vasa recta, which are essential for maintaining the medullary osmolar gradient. The presence of two arteriolar resistance vessels in series -- the afferent and efferent arterioles -- is a feature unique to the renal circulation and is critical for the precise regulation of glomerular filtration pressure independent of systemic hemodynamics.

Microvascular Physiology

Glomerular capillaries operate at significantly higher hydrostatic pressures compared to systemic capillary beds, typically in the range of 45 to 50 mmHg versus 15 to 25 mmHg in most other capillaries. This elevated pressure is essential for driving ultrafiltration across the glomerular filtration barrier. In contrast, the peritubular capillaries operate at low hydrostatic pressure and high oncotic pressure, conditions that favor the reabsorption of fluid and solutes from the tubular interstitium back into the vasculature. Medullary blood flow is notably low, representing only about 5 to 10 percent of total renal blood flow. This reduced flow is physiologically critical because it prevents the washout of the hyperosmolar medullary interstitial gradient, which is required for urinary concentration. The vasa recta function as countercurrent exchangers, allowing solute and water to equilibrate between the descending and ascending limbs without disrupting the medullary tonicity gradient.

<image>Detailed anatomical diagram of the nephron vasculature showing the afferent arteriole, glomerular capillary tuft, efferent arteriole, peritubular capillaries, and vasa recta. Label the hydrostatic and oncotic pressures at each segment. Include arrows indicating direction of blood flow and filtration forces. Show both cortical and juxtamedullary nephron variants side by side with their distinct vascular patterns.</image>

Determinants of Glomerular Filtration Rate

Starling Forces Across the Glomerular Capillary

The glomerular filtration rate is governed by the classic Starling equation applied to the glomerular capillary: GFR equals the ultrafiltration coefficient (Kf) multiplied by the net ultrafiltration pressure. The net ultrafiltration pressure is the algebraic sum of the four Starling forces: glomerular capillary hydrostatic pressure (PGC, approximately 45 to 50 mmHg) favoring filtration, Bowman's space hydrostatic pressure (PBS, approximately 10 to 15 mmHg) opposing filtration, glomerular capillary oncotic pressure (piGC, which rises progressively from about 20 mmHg at the afferent end to approximately 35 mmHg at the efferent end as protein-free filtrate is removed and plasma proteins become concentrated) opposing filtration, and Bowman's space oncotic pressure (piBS, essentially zero in health because the filtration barrier normally excludes macromolecules). The net ultrafiltration pressure is therefore highest at the afferent end of the capillary, approximately 10 to 15 mmHg, and decreases progressively along the length of the capillary as oncotic pressure rises. At the efferent end, filtration equilibrium may be reached, meaning that the net driving pressure approaches zero and filtration ceases. Whether true filtration equilibrium is achieved in human kidneys remains a matter of some debate, but this concept has important implications for understanding how changes in plasma flow affect GFR.

Filtration Fraction

The filtration fraction is defined as the ratio of GFR to renal plasma flow (RPF), and under normal physiologic conditions it is approximately 18 to 20 percent. Changes in the filtration fraction have direct consequences for peritubular capillary dynamics and therefore for proximal tubular reabsorption. When the filtration fraction is increased, as occurs with efferent arteriolar constriction by angiotensin II, the oncotic pressure in the peritubular capillaries rises because a greater proportion of plasma water has been filtered, leaving a more concentrated plasma behind. This elevated peritubular oncotic pressure enhances proximal tubular reabsorption of sodium and water. Conversely, when the filtration fraction decreases, as may occur with afferent arteriolar constriction or after administration of ACE inhibitors or angiotensin receptor blockers, the peritubular oncotic pressure falls and proximal reabsorption is reduced.

Ultrafiltration Coefficient (Kf)

The ultrafiltration coefficient is the product of the hydraulic permeability of the glomerular capillary wall and the total capillary surface area available for filtration. It therefore reflects both the intrinsic porosity of the filtration barrier and the total filtration surface. Mesangial cells, which are contractile cells embedded within the glomerular mesangium, play a regulatory role by modifying the capillary surface area. Contraction of mesangial cells, stimulated by mediators such as angiotensin II and endothelin, reduces the effective filtration surface area and thereby decreases Kf. Relaxation of mesangial cells, promoted by atrial natriuretic peptide, nitric oxide, and prostaglandins, increases filtration surface area and raises Kf. In disease states such as diabetic nephropathy and focal segmental glomerulosclerosis, structural damage to the glomerular capillary wall and loss of capillary surface area reduce Kf, contributing to the decline in GFR.

Autoregulation of Renal Blood Flow and GFR

Myogenic Response (Bayliss Effect)

The myogenic response is an intrinsic property of vascular smooth muscle in the afferent arteriole that allows it to respond to changes in transmural pressure. When renal perfusion pressure increases, the resulting stretch of the afferent arteriolar wall triggers vasoconstriction through activation of mechanosensitive ion channels, including TRPC6 and epithelial sodium channels. This vasoconstriction increases afferent arteriolar resistance and prevents the transmission of elevated systemic pressures to the glomerular capillary bed. The myogenic response operates rapidly, within 2 to 5 seconds of a pressure change, and is the first line of defense in autoregulation. Together with tubuloglomerular feedback, the myogenic mechanism maintains renal blood flow and GFR relatively constant across a wide range of mean arterial pressures, typically from 80 to 180 mmHg. Below and above these limits, autoregulation is overwhelmed and GFR becomes pressure-dependent.

Tubuloglomerular Feedback (TGF)

Tubuloglomerular feedback is a local paracrine mechanism that links tubular flow rate to glomerular hemodynamics through the juxtaglomerular apparatus. The macula densa, a group of specialized epithelial cells in the thick ascending limb of the loop of Henle, senses the chloride concentration (and indirectly the sodium chloride delivery) in the tubular fluid via the apical Na-K-2Cl cotransporter NKCC2. When sodium chloride delivery to the macula densa increases, indicating a rise in GFR, the macula densa cells release ATP and adenosine. Adenosine acts on A1 receptors on the afferent arteriole, causing vasoconstriction and thereby reducing glomerular capillary pressure and GFR. This constitutes a negative feedback loop that protects the glomerulus from hyperfiltration. Conversely, when sodium chloride delivery to the macula densa decreases, adenosine release diminishes, the afferent arteriole dilates, and renin is released from the juxtaglomerular cells, activating the renin-angiotensin system and promoting efferent vasoconstriction to maintain GFR. The response time of tubuloglomerular feedback is approximately 10 to 20 seconds, and this mechanism accounts for roughly 50 percent of total autoregulatory capacity.

Third Mechanism (Connecting Tubule Glomerular Feedback)

A third autoregulatory mechanism, connecting tubule glomerular feedback, has been described in which connecting tubule cells sense sodium delivery through the epithelial sodium channel ENaC. Unlike the classical TGF mechanism, increased sodium delivery at this downstream site causes afferent arteriolar dilation rather than constriction, mediated by prostaglandins and epoxyeicosatrienoic acids. This feedback operates in the opposite direction to TGF and may serve to fine-tune glomerular hemodynamics in states of altered distal sodium delivery.

<image>Flowchart illustrating the tubuloglomerular feedback mechanism. Start with increased GFR leading to increased NaCl delivery to the macula densa. Show NKCC2-mediated NaCl uptake, ATP release, conversion to adenosine via ecto-5'-nucleotidase, adenosine A1 receptor activation on afferent arteriole causing vasoconstriction, and the resulting decrease in GFR forming a negative feedback loop. Include a parallel pathway showing decreased NaCl delivery leading to renin release from juxtaglomerular cells and the renin-angiotensin cascade.</image>

Neurohormonal Regulation

Renin-Angiotensin-Aldosterone System (RAAS)

Renin secretion from the juxtaglomerular cells is stimulated by three principal signals: decreased renal perfusion pressure sensed by the baroreceptor mechanism in the afferent arteriole, increased sympathetic tone acting through beta-1 adrenergic receptors on juxtaglomerular cells, and decreased sodium chloride delivery at the macula densa. Renin cleaves angiotensinogen to angiotensin I, which is subsequently converted by angiotensin-converting enzyme to angiotensin II. Angiotensin II preferentially constricts the efferent arteriole, owing to its higher density of AT1 receptors relative to the afferent arteriole. This efferent vasoconstriction maintains glomerular capillary hydrostatic pressure and preserves GFR even when renal blood flow is reduced, as in states of effective volume depletion. However, this compensatory mechanism is a double-edged sword: in conditions of pronounced RAAS activation such as congestive heart failure, hepatic cirrhosis, and volume depletion, the introduction of ACE inhibitors or angiotensin receptor blockers removes the efferent arteriolar tone that was sustaining GFR, potentially precipitating acute kidney injury. Aldosterone, the downstream effector of the RAAS, promotes sodium retention in the collecting duct, contributing to volume expansion and blood pressure elevation.

Sympathetic Nervous System

The renal sympathetic nerves innervate the afferent and efferent arterioles, the juxtaglomerular cells, and the tubular epithelium throughout the nephron. At low levels of sympathetic activation, the primary effects are increased renin secretion and enhanced proximal tubular sodium reabsorption, with relatively little impact on renal blood flow or GFR. However, at high levels of sympathetic activation, as may occur during hemorrhagic shock or severe heart failure, both afferent and efferent arteriolar vasoconstriction occurs, reducing renal blood flow and GFR substantially. Renal denervation studies, including the SYMPLICITY HTN-3 and SPYRAL HTN-OFF MED trials, have explored the role of renal sympathetic nerves in hypertension and demonstrated modest blood pressure reductions, supporting the clinical relevance of this pathway.

Vasoactive Mediators

A complex interplay of vasodilatory and vasoconstrictive mediators maintains the balance of renal vascular tone. Important vasodilators include nitric oxide produced by endothelial and neuronal nitric oxide synthases, prostaglandins PGE2 and prostacyclin, bradykinin, atrial and B-type natriuretic peptides, and dopamine. Key vasoconstrictors include angiotensin II, endothelin-1 acting through ETA receptors, thromboxane A2, adenosine acting on afferent arteriolar A1 receptors, and antidiuretic hormone acting through V1 receptors. Nonsteroidal anti-inflammatory drugs inhibit prostaglandin synthesis and thereby remove the protective vasodilatory tone of the afferent arteriole. When NSAIDs are combined with ACE inhibitors or angiotensin receptor blockers and diuretics, the result is the so-called "triple whammy," a combination that dramatically increases the risk of acute kidney injury by simultaneously reducing renal blood flow, removing efferent arteriolar tone, and depleting effective circulating volume.

Measurement of GFR

Gold Standard Methods

The gold standard for measuring GFR is the renal clearance of inulin, a fructose polymer that is freely filtered at the glomerulus without being reabsorbed, secreted, synthesized, or metabolized by the kidney. Inulin clearance requires a constant intravenous infusion to achieve steady-state plasma levels and precisely timed urine collections, making it impractical for routine clinical use. Iothalamate clearance, using the radiolabeled isotope 125I-iothalamate, is widely considered the reference standard in clinical trials and is performed via nuclear medicine techniques. More recently, iohexol clearance using a plasma disappearance method has gained increasing acceptance in research settings, as demonstrated in the CKD-EPI iohexol studies, because it eliminates the need for urine collections.

Creatinine-Based Estimation

Creatinine is an endogenous byproduct of skeletal muscle creatine metabolism and is the most commonly used marker for estimating GFR in clinical practice. Creatinine is freely filtered at the glomerulus and is also secreted in small amounts by the proximal tubule via the organic cation transporter 2 and multidrug and toxin extrusion transporters. This tubular secretion means that creatinine clearance overestimates true GFR by approximately 10 to 15 percent. The CKD-EPI 2021 equation, which is race-free and was recommended by the National Kidney Foundation and American Society of Nephrology Task Force, is the current standard for estimating GFR from serum creatinine. Important limitations of creatinine-based estimation include variability with muscle mass, dietary creatine intake, and the effect of certain drugs -- specifically trimethoprim, cimetidine, and cobicistat -- that inhibit tubular creatinine secretion and raise serum creatinine without actually reducing true GFR.

Cystatin C-Based Estimation

Cystatin C is a 13-kilodalton cysteine protease inhibitor produced at a constant rate by all nucleated cells. It is freely filtered at the glomerulus and is completely reabsorbed and catabolized by the proximal tubule, meaning that urinary cystatin C measurement is not useful but serum cystatin C reflects GFR. Because cystatin C production is independent of muscle mass, diet, and sex, it is less affected by the confounders that limit creatinine-based estimates. However, cystatin C levels are influenced by thyroid function (hyperthyroidism increases production), obesity, systemic inflammation, and corticosteroid use. CKD-EPI equations incorporating cystatin C alone or in combination with creatinine are available, and the combined creatinine-cystatin C equation provides the most accurate estimation. Cystatin C-based estimation is particularly recommended when creatinine-based eGFR may be inaccurate, such as in patients with extremes of muscle mass, amputations, or sarcopenia.

Measured Creatinine Clearance

The 24-hour urine creatinine clearance is calculated as the product of urine creatinine concentration and urine volume divided by plasma creatinine concentration. Because of tubular creatinine secretion, this method overestimates true GFR, though it remains useful in clinical scenarios where estimating equations are unreliable, including extremes of body size, amputees, and pregnancy. The Cockcroft-Gault equation, which estimates creatinine clearance rather than GFR, is still used by the FDA for drug dosing labeling, though it has largely been supplanted by the CKD-EPI equations for most other clinical purposes.

<image>Comparison chart showing the filtration, reabsorption, and secretion characteristics of the three main GFR markers: inulin, creatinine, and cystatin C. Include a table with columns for molecular weight, production source, filtration characteristics, tubular handling, factors affecting levels, and clinical equations used. Add a graph overlay showing how measured clearance compares to true GFR for each marker across different GFR ranges.</image>

Clinical Applications

Hemodynamic AKI

Pre-renal acute kidney injury results from decreased renal blood flow due to volume depletion, cardiorenal syndrome with low cardiac output, or hepatorenal syndrome. In these states, tubular function remains intact, and the fractional excretion of sodium is characteristically less than 1 percent and the fractional excretion of urea less than 35 percent, reflecting avid sodium and water reabsorption. ACE inhibitor- or angiotensin receptor blocker-related AKI occurs through loss of efferent arteriolar tone in states where GFR is critically dependent on RAAS-mediated efferent vasoconstriction. NSAID-related AKI results from loss of prostaglandin-mediated afferent arteriolar vasodilation, reducing glomerular capillary perfusion.

Hyperfiltration

When nephron mass is reduced, the remaining nephrons undergo compensatory hyperfiltration, with increases in single-nephron GFR to maintain overall renal function. This phenomenon is observed in patients with a solitary kidney, after nephrectomy, in obesity-related glomerulopathy, and in early diabetic nephropathy. While initially adaptive, sustained hyperfiltration leads to glomerular hypertension, mechanical podocyte stress, proteinuria, and progressive nephron loss, as described in the Brenner hypothesis. SGLT2 inhibitors reduce hyperfiltration by increasing sodium chloride delivery to the macula densa, which activates tubuloglomerular feedback and promotes afferent arteriolar vasoconstriction, thereby lowering intraglomerular pressure. The major clinical trials -- EMPA-KIDNEY, DAPA-CKD, and CREDENCE -- have demonstrated that the renoprotective effects of SGLT2 inhibitors are mediated through both hemodynamic mechanisms, including the reduction of hyperfiltration, and non-hemodynamic mechanisms, including anti-inflammatory and anti-fibrotic effects.

Renal Reserve

Renal reserve refers to the capacity of the kidneys to augment GFR by approximately 20 to 30 percent above baseline in response to a protein load or amino acid infusion. This augmentation reflects the recruitment of hyperfiltration capacity in nephrons that are not functioning at maximal capacity under basal conditions. Loss of renal reserve may serve as an early marker of subclinical kidney disease, detectable before any decline in baseline GFR. Testing for renal reserve is typically performed by administering an oral protein load of 1 gram per kilogram body weight or an intravenous amino acid infusion, followed by serial GFR measurements.

Key Clinical Pearls

• Angiotensin II preferentially constricts the efferent arteriole, which is why ACEi/ARB reduce GFR in RAAS-dependent states but are renoprotective long-term by reducing intraglomerular pressure
• A 20-30% rise in creatinine after ACEi/ARB initiation is expected and acceptable; only discontinue if creatinine rises >30% or hyperkalemia develops
• NSAIDs cause AKI by blocking afferent arteriolar prostaglandin-mediated vasodilation; risk is amplified with concurrent RAAS blockade and diuretics
• SGLT2 inhibitors cause an initial "dip" in eGFR (hemodynamic, not structural) analogous to ACEi/ARB; this reflects reduced intraglomerular pressure and predicts long-term benefit
• Cystatin C should be used to confirm eGFR in patients with extremes of muscle mass or when creatinine-based estimates are unreliable

References

1. Denic A, Mathew J, Lerman LO, et al. Single-Nephron Glomerular Filtration Rate in Healthy Adults. N Engl J Med. 2017;376(24):2349-2357.
2. Schnermann J, Briggs JP. Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice. Kidney Int. 2008;74(4):418-426.
3. Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737-1749.
4. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int. 1996;49(6):1774-1777.
5. Vallon V, Thomson SC. The tubular hypothesis of nephron filtration and diabetic kidney disease. Nat Rev Nephrol. 2020;16(6):317-336.

Read this lecture as Markdown